[1] Sahebjam F, Vierling JM. Autoimmune hepatitis. Front Med, 2015, 9:187-219.
[2] Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis, 2015, 19:57-79.
[3] Grunebaum E, Cohen A, Roifman CM. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr Opin Allergy Clin Immunol, 2013, 13:630-638.
[4] Antonioli L, Colucci R, La Motta C, et al. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets, 2012, 13:842-862.
[5] Saghiri R, Ghashghai N, Movaseghi S, et al. Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatol Int, 2012, 32:1633-1638.
[6] Doudkani-Fard M, Ziaee V, Moradinejad MH, et al. Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis. Med J Islam Repub Iran, 2014, 28:113.
[7] Maor I, Rainis T, Lanir A, et al. Adenosine deaminase activity in patients with Crohn’s disease: distinction between active and nonactive disease. Eur J Gastroenterol Hepatol, 2011, 23:598-602.
[8] Kaya S, Cetin ES, Aridogan BC, et al. Adenosine deaminase activity in serum of patients with hepatitis- a useful tool in monitoring clinical status. J Microbiol Immunol Infect, 2007, 40:288-292.
[9] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48:169-176.
[10] Dhaliwal HK, Hoeroldt BS, Dube AK, et al. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis. Am J Gastroenterol, 2015, 110:993-999.
[11] Gutkowski K, Hartleb M, Kacperek-Hartleb T, et al. Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int, 2013, 33:1370-1377.
[12] Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol, 2014, 60:210-223.
[13] Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology, 2014, 147:765-783.e4.
[14] Xun C, Zhao Y, Hu ZJ. Potential role of adenosine deaminase in the diagnosis of adult-onset Still’s disease. Rheumatol Int, 2013, 33:1255-1258. |
